Although these correlations need to be validated in large prospective studies, our findings suggest that, together with other confounding factors of disease progression, analysis of the molecular status of the RPH3AL gene would aid in understanding the aggressiveness of a sub-set of breast cancers and in designing optimal treatment regimens. The gene discussed is RPH3AL; the disease is breast carcinoma.